This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Queen's University directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $2,184,076
A Liquid-Biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-Inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
CIHR · 2022 · Co-investigator
- $860,628
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
CIHR · 2018 · Principal investigator
- $100,000
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
CIHR · 2017 · Principal investigator
A Liquid-Biopsy Informed Platform Trial to Evaluate Treatment in CDK4/6-Inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Principal investigators: Rushton-Marovac, Moira K; Cescon, David W; Seymour, Lesley
Keywords: Aromatase Inhibitor And Cdk4/6 Inhibitor Resistance; Biomarker; Circulating Tumour Cells (Ctcs); Circulating Tumour Dna (Ctdna); Hormone-Positive Metastatic Breast Cancer; Liquid Biopsy; Platform Trial; Umbrella Trial
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
Principal investigators: Parulekar, Wendy R; Bratman, Scott V
Keywords: Cooperative Group; De-Escalation; Head And Neck Cancer; Human Papillomavirus; Multi-Institutional; Oropharynx Cancer; Phase Ii Clinical Study; Radiotherapy
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
Principal investigators: Parulekar, Wendy R; Bratman, Scott V
Keywords: Cooperative Group; De-Escalation; Head And Neck Cancer; Human Papillomavirus; Multi-Institutional; Oropharynx Cancer; Phase Ii Clinical Study; Radiotherapy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.